Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

37.37 -1.18 (-3.06%)

Streaming Delayed Price Updated: 1:13 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

DNUT Stock Soars 29% as McDonald’s Deal Supercharges Krispy Kreme ↗

March 26, 2024

Krispy Kreme stock is rising higher on Tuesday with heavy trading of DNUT shares alongside a new collaboration agreement with McDonald’s.

Via InvestorPlace

Why Viking Therapeutics Stock Is Skyrocketing Today ↗

March 26, 2024

The high-flying biotech company delivered more good news about a weight loss drug candidate.

Via The Motley Fool

MSTR Stock Alert: MicroStrategy Releases New AI Bot ↗

March 26, 2024

MicroStrategy stock is up on Tuesday as investors in MSTR shares react to news of a new AI bot released by the data analytics company.

Via InvestorPlace

Topics Artificial Intelligence

Why Is Viking Therapeutics (VKTX) Stock Up 24% Today? ↗

March 26, 2024

Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.

Via InvestorPlace

Viking Therapeutics' Investigational Oral Obesity Drug Shows Reduced Weight In Small Study ↗

March 26, 2024

Explore Viking Therapeutics' Phase 1 MAD trial results for oral VK2735, a promising treatment for metabolic disorders like obesity. Dose-dependent reductions in body weight, encouraging...

Via Benzinga

Viking Therapeutics: Buy, Sell, or Hold? ↗

March 26, 2024

It has a promising candidate and plenty of cash in hand.

Via The Motley Fool

2 Incredible Growth Stocks to Buy Right Now ↗

March 20, 2024

These two biotech stocks could be big winners in the years ahead.

Via The Motley Fool

Viking Therapeutics Unusual Options Activity For March 19 ↗

March 19, 2024

Via Benzinga

Warning: This Skyrocketing Stock Has a Hidden Risk ↗

March 19, 2024

Don't bet on this pitfall happening, but know that it's a possibility.

Via The Motley Fool

Viking Surges After Weight-Loss Pill Tops Expectations In Just 28 Days ↗

March 26, 2024

People lost more weight than the company expected over a 28-day study.

Via Investor's Business Daily

Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics? ↗

March 26, 2024

All three of these high-flying stocks could have more room to run.

Via The Motley Fool

2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street ↗

March 26, 2024

Find out why investment banks up and down Wall Street have big expectations for these stocks.

Via The Motley Fool

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗

March 25, 2024

Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Via InvestorPlace

Novo Nordisk and Eli Lilly May Finally Have Some Real Competition ↗

March 25, 2024

Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.

Via The Motley Fool

Where Will Viking Therapeutics Be in 5 Years? ↗

March 17, 2024

Expectations for the stock are high, and it could well deliver.

Via The Motley Fool

Will Viking Therapeutics Get Acquired? ↗

March 16, 2024

Would an acquisition be good news for Viking Therapeutics investors?

Via The Motley Fool

Check Out What Whales Are Doing With VKTX ↗

March 14, 2024

Via Benzinga

Is Viking Therapeutics Stock a Millionaire Maker? ↗

March 24, 2024

Viking Therapeutics has become one of the hottest healthcare stocks of 2024.

Via The Motley Fool

Where Will Viking Therapeutics Stock Be in 10 Years? ↗

March 23, 2024

Viking's future appears to be very promising, but market dynamics can change.

Via The Motley Fool

With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk? ↗

March 22, 2024

The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.

Via The Motley Fool

Could Viking Therapeutics Become the Next Eli Lilly? ↗

March 22, 2024

Viking shares have skyrocketed on its recent good news.

Via The Motley Fool

Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst ↗

March 21, 2024

The company might enter the hottest segment in the pharmaceutical sphere before long.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 20, 2024

Via Benzinga

Peering Into Viking Therapeutics's Recent Short Interest ↗

March 13, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

March 19, 2024

Via Benzinga

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

2 Stocks That Have More Than Tripled This Year: Are They Buys? ↗

March 15, 2024

Don't jump on the bandwaggon too quickly.

Via The Motley Fool

Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market? ↗

March 15, 2024

Viking Therapeutics just might be an attractive acquisition target for Pfizer.

Via The Motley Fool

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Via InvestorPlace

Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March ↗

March 13, 2024

This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024.

Via InvestorPlace

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.